78 / 198
SEB
Working Group Members
Sandra Tallent, FDA (Chair)
Jessica Appler HHS BARDA
Karen Kesterson, PFPA
Katalin Kiss ATCC
,
Patrice Arbault, BioAdvantage
Consulting
Jeff Ballin, ECBC
Linda Beck, Naval Surface
Warfare Center
Don Bushner, JRO-CBRND
Ryan Cahall, Censeo Insight
Matthew Davenport, DHS
,
Markus Lacorn, R-Biopharm
Metthew Lesho, Luminex
Stephen Morse, CDC
Sean O’Brien, DoD DUSA T-E
Kate Ong, JPEO-CBD
Tom Phillips, MD Department of
Agriculture
Roberto Rebeil, ECBC
Martha Hale, USAMRIID
Kia Hopkins, ECBC
Malcolm Johns, DHS
Liz Kerrigan, ATCC
Reinhardt Witzenberger, R-
Biopharm
Emily Yost, ATEC
SEB Working Group
Work to Date
•
2 In Person Meetings
•
3 teleconferences (March 2015 – May 2015)
•
1 SMPR Drafted
•
Public comment period (June 30, 2015 – July
31 2015)
,
•
SMPRs made ready for SPADA review and
approval